Skip to main content
. 2016 Jan 27;11:399–411. doi: 10.2147/IJN.S84927

Figure 10.

Figure 10

The results of HepG2 cells transfected with anti-miR-221 using PCPH NPs.

Notes: (A) Relative expression change of miR-221 level in HepG2 cells. (B) Western blot analysis of p27Kip1 in the HepG2 cells after treatment with different formulations. (C) Cell cycle profiles of HepG2 cells after treatment with different formations; (D) cell proliferation of HepG2 cells after treatment with different formations (images obtained 3 days after treatment); (a) untreated group; (b) pure PCPH NPs; (c) PCPH/mismatched AMO-transfected HepG2 cells; (d) PCPH/anti-miR-221-transfected HepG2 cells. Magnification of the images is 200×.

Abbreviations: PCPH, polylactic-co-glycolic acid/cetylated polyethyleneimine/hyaluronic acid; NPs, nanoparticles; AMO, anti-microRNA oligonucleotide; miR, microRNA; NC, negative control.